Browse By Cancer Type Result Page of OvirusTdb

The total number of records retrieved from this search are 100. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_1829Vesicular stomatitis virusMutantRNARhabdoviridaevirus expressing SV5-F geneYesNoNoATCCProstate cancer cell lineTRAMP-C22.0E+3 cells per wellNAMTT assay5 MOI50% cell survival after 120 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsNANA20172545
OV_1830Vesicular stomatitis virusMutantRNARhabdoviridaevirus expressing SV5-F geneYesNoNoATCCProstate cancer cell lineTRAMP-C22.0E+3 cells per wellNAMTT assay10 MOI80% cell survival after 24 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsNANA20172545
OV_1831Vesicular stomatitis virusMutantRNARhabdoviridaevirus expressing SV5-F geneYesNoNoATCCProstate cancer cell lineTRAMP-C22.0E+3 cells per wellNAMTT assay10 MOI60% cell survival after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsNANA20172545
OV_1832Vesicular stomatitis virusMutantRNARhabdoviridaevirus expressing SV5-F geneYesNoNoATCCProstate cancer cell lineTRAMP-C22.0E+3 cells per wellNAMTT assay10 MOI40% cell survival after 72 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsNANA20172545
OV_1833Vesicular stomatitis virusMutantRNARhabdoviridaevirus expressing SV5-F geneYesNoNoATCCProstate cancer cell lineTRAMP-C22.0E+3 cells per wellNAMTT assay10 MOI20% cell survival after 96 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsNANA20172545
OV_1834Vesicular stomatitis virusMutantRNARhabdoviridaevirus expressing SV5-F geneYesNoNoATCCProstate cancer cell lineTRAMP-C22.0E+3 cells per wellNAMTT assay10 MOI10% cell survival after 120 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsNANA20172545
OV_1835Vesicular stomatitis virusMutantRNARhabdoviridaevirus expressing SV5-F geneYesNoNoATCCProstate cancer cell lineTRAMP-C22.0E+3 cells per wellNAMTT assay50 MOI60% cell survival after 24 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsNANA20172545
OV_1836Vesicular stomatitis virusMutantRNARhabdoviridaevirus expressing SV5-F geneYesNoNoATCCProstate cancer cell lineTRAMP-C22.0E+3 cells per wellNAMTT assay50 MOI20% cell survival after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsNANA20172545
OV_1837Vesicular stomatitis virusMutantRNARhabdoviridaevirus expressing SV5-F geneYesNoNoATCCProstate cancer cell lineTRAMP-C22.0E+3 cells per wellNAMTT assay50 MOI10% cell survival after 72 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsNANA20172545
OV_1838Vesicular stomatitis virusMutantRNARhabdoviridaevirus expressing SV5-F geneYesNoNoATCCProstate cancer cell lineTRAMP-C22.0E+3 cells per wellNAMTT assay50 MOI100% cell killingNoNoNA No responseNAVirus induce apoptosis in cancer cellsNANA20172545
OV_1839Vesicular stomatitis virusMutantRNARhabdoviridaevirus expressing SV5-F geneYesNoNoATCCProstate cancer cell lineTRAMP-C22.0E+3 cells per wellNAMTT assay50 MOI100% cell killingNoNoNA No responseNAVirus induce apoptosis in cancer cellsNANA20172545
OV_2014ReovirusReovirus T3DRNAReoviridaeNoneYesNoNoNAHuman prostate cancer cell linePC-35.0E+3 cells per wellNAMTS assay0.1 MOI70% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2015ReovirusReovirus T3DRNAReoviridaeNoneYesNoNoNAHuman prostate cancer cell linePC-35.0E+3 cells per wellNAMTS assay1 MOI30% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2016ReovirusReovirus T3DRNAReoviridaeNoneYesNoNoNAHuman prostate cancer cell linePC-35.0E+3 cells per wellNAMTS assay10 MOI10% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2017ReovirusReovirus T3DRNAReoviridaeNoneYesNoNoNAHuman prostate cancer cell linePC-35.0E+3 cells per wellNAMTS assay100 MOI100% cell deathNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2018ReovirusReovirus T3DRNAReoviridaeNoneYesNoNoNAHuman prostate cancer cell lineLNCaP7.5E+3 cells per wellNAMTS assay0.1 MOI90% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2019ReovirusReovirus T3DRNAReoviridaeNoneYesNoNoNAHuman prostate cancer cell lineLNCaP7.5E+3 cells per wellNAMTS assay1 MOI60% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2020ReovirusReovirus T3DRNAReoviridaeNoneYesNoNoNAHuman prostate cancer cell lineLNCaP7.5E+3 cells per wellNAMTS assay10 MOI20% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2021ReovirusReovirus T3DRNAReoviridaeNoneYesNoNoNAHuman prostate cancer cell lineLNCaP7.5E+3 cells per wellNAMTS assay100 MOI100% cell deathNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2022ReovirusReovirus T3DRNAReoviridaeNoneYesNoNoNAHuman prostate cancer cell lineDu1457.5E+3 cells per wellNAMTS assay0.1 MOI100% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2023ReovirusReovirus T3DRNAReoviridaeNoneYesNoNoNAHuman prostate cancer cell lineDu1457.5E+3 cells per wellNAMTS assay1 MOI100% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2024ReovirusReovirus T3DRNAReoviridaeNoneYesNoNoNAHuman prostate cancer cell lineDu1457.5E+3 cells per wellNAMTS assay10 MOI70% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2025ReovirusReovirus T3DRNAReoviridaeNoneYesNoNoNAHuman prostate cancer cell lineDu1457.5E+3 cells per wellNAMTS assay100 MOI10% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2026ReovirusReovirus T3DRNAReoviridaeNoneNoVirus strain in combination with Docetaxel (7.5 nM)NoNAHuman prostate cancer cell linePC-35.0E+3 cells per wellNAMTS assay0.125 MOI80% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2027ReovirusReovirus T3DRNAReoviridaeNoneNoVirus strain in combination with Docetaxel (15 nM)NoNAHuman prostate cancer cell linePC-35.0E+3 cells per wellNAMTS assay0.25 MOI70% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2028ReovirusReovirus T3DRNAReoviridaeNoneNoVirus strain in combination with Docetaxel (30 nM)NoNAHuman prostate cancer cell linePC-35.0E+3 cells per wellNAMTS assay0.5 MOI60% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2029ReovirusReovirus T3DRNAReoviridaeNoneNoVirus strain in combination with Docetaxel (60 nM)NoNAHuman prostate cancer cell linePC-35.0E+3 cells per wellNAMTS assay1 MOI50% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2030ReovirusReovirus T3DRNAReoviridaeNoneNoVirus strain in combination with Docetaxel (120 nM)NoNAHuman prostate cancer cell linePC-35.0E+3 cells per wellNAMTS assay2 MOI40% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2031ReovirusReovirus T3DRNAReoviridaeNoneNoVirus strain in combination with Docetaxel (7.5 nM)NoNAHuman prostate cancer cell lineLNCaP7.5E+3 cells per wellNAMTS assay0.125 MOI70% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2032ReovirusReovirus T3DRNAReoviridaeNoneNoVirus strain in combination with Docetaxel (15 nM)NoNAHuman prostate cancer cell lineLNCaP7.5E+3 cells per wellNAMTS assay0.25 MOI70% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2033ReovirusReovirus T3DRNAReoviridaeNoneNoVirus strain in combination with Docetaxel (30 nM)NoNAHuman prostate cancer cell lineLNCaP7.5E+3 cells per wellNAMTS assay0.5 MOI60% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2034ReovirusReovirus T3DRNAReoviridaeNoneNoVirus strain in combination with Docetaxel (60 nM)NoNAHuman prostate cancer cell lineLNCaP7.5E+3 cells per wellNAMTS assay1 MOI50% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2035ReovirusReovirus T3DRNAReoviridaeNoneNoVirus strain in combination with Docetaxel (120 nM)NoNAHuman prostate cancer cell lineLNCaP7.5E+3 cells per wellNAMTS assay2 MOI40% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2036ReovirusReovirus T3DRNAReoviridaeNoneNoVirus strain in combination with Docetaxel (120 nM)NoNAHuman prostate cancer cell lineDu1457.5E+3 cells per wellNAMTS assay0.125 MOI60% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2037ReovirusReovirus T3DRNAReoviridaeNoneNoVirus strain in combination with Docetaxel (120 nM)NoNAHuman prostate cancer cell lineDu1457.5E+3 cells per wellNAMTS assay0.25 MOI45% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2038ReovirusReovirus T3DRNAReoviridaeNoneNoVirus strain in combination with Docetaxel (120 nM)NoNAHuman prostate cancer cell lineDu1457.5E+3 cells per wellNAMTS assay0.5 MOI30% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2039ReovirusReovirus T3DRNAReoviridaeNoneNoVirus strain in combination with Docetaxel (120 nM)NoNAHuman prostate cancer cell lineDu1457.5E+3 cells per wellNAMTS assay1 MOI20% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2040ReovirusReovirus T3DRNAReoviridaeNoneNoVirus strain in combination with Docetaxel (120 nM)NoNAHuman prostate cancer cell lineDu1457.5E+3 cells per wellNAMTS assay2 MOI20% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2041ReovirusReovirus T3DRNAReoviridaeNoneNovirus in combination with Docetaxel (7.5)NoNAHuman prostate cancer cell lineDu1457.5E+3 cells per wellMTS assay2.15 MOI70% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2042ReovirusReovirus T3DRNAReoviridaeNoneNoVirus strain in combination with Docetaxel (15 nM)NoNAHuman prostate cancer cell lineDu1457.5E+3 cells per wellMTS assay4.3 MOI50% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2043ReovirusReovirus T3DRNAReoviridaeNoneNoVirus strain in combination with Docetaxel (30 nM)NoNAHuman prostate cancer cell lineDu1457.5E+3 cells per wellMTS assay8.6 MOI30% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2044ReovirusReovirus T3DRNAReoviridaeNoneNoVirus strain in combination with Docetaxel (60 nM)NoNAHuman prostate cancer cell lineDu1457.5E+3 cells per wellMTS assay17.2 MOI10% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2045ReovirusReovirus T3DRNAReoviridaeNoneNoVirus strain in combination with Docetaxel (120 nM)NoNAHuman prostate cancer cell lineDu1457.5E+3 cells per wellMTS assay34.4 MOI10% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2046ReovirusReovirus T3DRNAReoviridaeNoneNoVirus strain in combination with Docetaxel (5 mg/kg)NoNAHuman prostate cancer cell lineLNCaPNANANANANAMice injected with PC3 cell line1.0E+8 pfuNA Reduction in tumor volume after day 15IntratumoralVirus cause increase in apoptosisNANA21645351
OV_3163Semliki forest virusSFV-VA7RNATogaviridaeNoneYesNoNoATCCHuman prostate cancer cell line22Rv140000 cells per wellNACell proliferation kit 1 assay0.01 MOI100% cell deathNoNoNA No responseNANANANA28557974
OV_3164Semliki forest virusSFV-VA7RNATogaviridaeNoneYesNoNoATCCHuman prostate cancer cell line22Rv140000 cells per wellNACell proliferation kit 1 assay0.1 MOI100% cell deathNoNoNA No responseNANANANA28557974
OV_3165Semliki forest virusSFV-VA7RNATogaviridaeNoneYesNoNoATCCHuman prostate cancer cell line22Rv140000 cells per wellNACell proliferation kit 1 assay1 MOI100% cell deathNoNoNA No responseNANANANA28557974
OV_3166Semliki forest virusSFV-VA7RNATogaviridaeNoneYesNoNoATCCHuman prostate cancer cell line22Rv140000 cells per wellNACell proliferation kit 1 assay10 MOI100% cell deathNoNoNA No responseNANANANA28557974
OV_3167Semliki forest virusSFV-VA7RNATogaviridaeNoneYesNoNoATCCHuman prostate cancer cell lineVCaP40000 cells per wellNACell proliferation kit 1 assay0.01 MOI100% cell deathNoNoNA No responseNANANANA28557974
OV_3168Semliki forest virusSFV-VA7RNATogaviridaeNoneYesNoNoATCCHuman prostate cancer cell lineVCaP40000 cells per wellNACell proliferation kit 1 assay0.1 MOI100% cell deathNoNoNA No responseNANANANA28557974
OV_3169Semliki forest virusSFV-VA7RNATogaviridaeNoneYesNoNoATCCHuman prostate cancer cell lineVCaP40000 cells per wellNACell proliferation kit 1 assay1 MOI100% cell deathNoNoNA No responseNANANANA28557974
OV_3170Semliki forest virusSFV-VA7RNATogaviridaeNoneYesNoNoATCCHuman prostate cancer cell lineVCaP40000 cells per wellNACell proliferation kit 1 assay10 MOI100% cell deathNoNoNA No responseNANANANA28557974
OV_3171Semliki forest virusSFV-VA7RNATogaviridaeNoneYesNoNoATCCHuman prostate cancer cell lineLNCaP40000 cells per wellNACalcein AM assay0.01 MOI100% cell deathNoNoNA No responseNANANANA28557974
OV_3172Semliki forest virusSFV-VA7RNATogaviridaeNoneYesNoNoATCCHuman prostate cancer cell lineLNCaP40000 cells per wellNACalcein AM assay0.1 MOI100% cell deathNoNoNA No responseNANANANA28557974
OV_3173Semliki forest virusSFV-VA7RNATogaviridaeNoneYesNoNoATCCHuman prostate cancer cell lineLNCaP40000 cells per wellNACalcein AM assay1 MOI100% cell deathNoNoNA No responseNANANANA28557974
OV_3174Semliki forest virusSFV-VA7RNATogaviridaeNoneYesNoNoATCCHuman prostate cancer cell lineLNCaP40000 cells per wellNACalcein AM assay10 MOI100% cell deathNoNoNA No responseNANANANA28557974
OV_3175Semliki forest virusSFV-VA7RNATogaviridaeNoneYesNoNoATCCHuman prostate cancer cell lineLNCaPNANANANANACAnM.Cg-Foxn1nu/Crl Balb/c nude mice subcutaneous xenograft for LNCaP (5.0E+6)1.0E+6 pfuNA Complete regression in tumor volume after 20 daysIntraperitonealNANANA28557974
OV_3176Semliki forest virusSFV-VA7RNATogaviridaeNoneYesNoNoATCCHuman prostate cancer cell lineLNCaPNANANANANACAnM.Cg-Foxn1nu/Crl Balb/c nude mice subcutaneous xenograft for LNCaP (5.0E+6)1.0E+6 pfuNA Complete regression in tumor volume after 20 daysIntraperitonealNANANA28557974
OV_3522AdenovirusAdenovirus ZD55DNAAdenoviridaeDeletion in E1B55 viral proteinYesNoNoShanghai cell collectionHuman prostate cancer cell lineDu1455000 cells per wellNAMTT assay1 MOI95% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3523AdenovirusAdenovirus ZD55DNAAdenoviridaeDeletion in E1B55 viral proteinYesNoNoShanghai cell collectionHuman prostate cancer cell lineDu1455000 cells per wellNAMTT assay5 MOI75% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3524AdenovirusAdenovirus ZD55DNAAdenoviridaeDeletion in E1B55 viral proteinYesNoNoShanghai cell collectionHuman prostate cancer cell lineDu1455000 cells per wellNAMTT assay10 MOI60% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3525AdenovirusAdenovirus ZD55DNAAdenoviridaeDeletion in E1B55 viral proteinYesNoNoShanghai cell collectionHuman prostate cancer cell lineDu1455000 cells per wellNAMTT assay20 MOI50% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3526AdenovirusAdenovirus GD55DNAAdenoviridaeGOLPH2 regulated aoncolytic adenovirusYesNoNoShanghai cell collectionHuman prostate cancer cell lineDu1455000 cells per wellNAMTT assay1 MOI70% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3527AdenovirusAdenovirus GD55DNAAdenoviridaeGOLPH2 regulated aoncolytic adenovirusYesNoNoShanghai cell collectionHuman prostate cancer cell lineDu1455000 cells per wellNAMTT assay5 MOI50% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3528AdenovirusAdenovirus GD55DNAAdenoviridaeGOLPH2 regulated aoncolytic adenovirusYesNoNoShanghai cell collectionHuman prostate cancer cell lineDu1455000 cells per wellNAMTT assay10 MOI40% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3529AdenovirusAdenovirus GD55DNAAdenoviridaeGOLPH2 regulated aoncolytic adenovirusYesNoNoShanghai cell collectionHuman prostate cancer cell lineDu1455000 cells per wellNAMTT assay20 MOI20% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3530AdenovirusAdenovirus ZD55DNAAdenoviridaeDeletion in E1B55 viral proteinYesNoNoShanghai cell collectionHuman prostate cancer cell lineLNCaP5000 cells per wellNAMTT assay1 MOI60% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3531AdenovirusAdenovirus ZD55DNAAdenoviridaeDeletion in E1B55 viral proteinYesNoNoShanghai cell collectionHuman prostate cancer cell lineLNCaP5000 cells per wellNAMTT assay5 MOI45% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3532AdenovirusAdenovirus ZD55DNAAdenoviridaeDeletion in E1B55 viral proteinYesNoNoShanghai cell collectionHuman prostate cancer cell lineLNCaP5000 cells per wellNAMTT assay10 MOI30% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3533AdenovirusAdenovirus ZD55DNAAdenoviridaeDeletion in E1B55 viral proteinYesNoNoShanghai cell collectionHuman prostate cancer cell lineLNCaP5000 cells per wellNAMTT assay20 MOI18% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3534AdenovirusAdenovirus GD55DNAAdenoviridaeGOLPH2 regulated aoncolytic adenovirusYesNoNoShanghai cell collectionHuman prostate cancer cell lineLNCaP5000 cells per wellNAMTT assay1 MOI45% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3535AdenovirusAdenovirus GD55DNAAdenoviridaeGOLPH2 regulated aoncolytic adenovirusYesNoNoShanghai cell collectionHuman prostate cancer cell lineLNCaP5000 cells per wellNAMTT assay5 MOI20% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3536AdenovirusAdenovirus GD55DNAAdenoviridaeGOLPH2 regulated aoncolytic adenovirusYesNoNoShanghai cell collectionHuman prostate cancer cell lineLNCaP5000 cells per wellNAMTT assay10 MOI20% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3537AdenovirusAdenovirus GD55DNAAdenoviridaeGOLPH2 regulated aoncolytic adenovirusYesNoNoShanghai cell collectionHuman prostate cancer cell lineLNCaP5000 cells per wellNAMTT assay20 MOI15% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3538AdenovirusAdenovirus ZD55DNAAdenoviridaeDeletion in E1B55 viral proteinYesNoNoShanghai cell collectionHuman prostate cancer cell linePC-35000 cells per wellNAMTT assay1 MOI90% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3539AdenovirusAdenovirus ZD55DNAAdenoviridaeDeletion in E1B55 viral proteinYesNoNoShanghai cell collectionHuman prostate cancer cell linePC-35000 cells per wellNAMTT assay5 MOI80% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3540AdenovirusAdenovirus ZD55DNAAdenoviridaeDeletion in E1B55 viral proteinYesNoNoShanghai cell collectionHuman prostate cancer cell linePC-35000 cells per wellNAMTT assay10 MOI70% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3541AdenovirusAdenovirus ZD55DNAAdenoviridaeDeletion in E1B55 viral proteinYesNoNoShanghai cell collectionHuman prostate cancer cell linePC-35000 cells per wellNAMTT assay20 MOI58% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3542AdenovirusAdenovirus GD55DNAAdenoviridaeGOLPH2 regulated aoncolytic adenovirusYesNoNoShanghai cell collectionHuman prostate cancer cell linePC-35000 cells per wellNAMTT assay1 MOI70% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3543AdenovirusAdenovirus GD55DNAAdenoviridaeGOLPH2 regulated aoncolytic adenovirusYesNoNoShanghai cell collectionHuman prostate cancer cell linePC-35000 cells per wellNAMTT assay5 MOI50% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3544AdenovirusAdenovirus GD55DNAAdenoviridaeGOLPH2 regulated aoncolytic adenovirusYesNoNoShanghai cell collectionHuman prostate cancer cell linePC-35000 cells per wellNAMTT assay10 MOI40% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3545AdenovirusAdenovirus GD55DNAAdenoviridaeGOLPH2 regulated aoncolytic adenovirusYesNoNoShanghai cell collectionHuman prostate cancer cell linePC-35000 cells per wellNAMTT assay20 MOI30% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3619Measles viruswild typeRNAParamyxoviridaeNoneYesNoNoATCCHuman prostate cancer cell linePC-35000 cells per wellNAMTT assay1 MOI60% cell viability after day 3NoNoNA No responseNAVirus in combination with induce apiptosis in cancer cellNANA29485292
OV_3620Measles viruswild typeRNAParamyxoviridaeNoneYesNoNoATCCHuman prostate cancer cell linePC-35000 cells per wellNAMTT assay1 MOI20% cell viability after day 6NoNoNA No responseNAVirus in combination with induce apiptosis in cancer cellNANA29485292
OV_3633Mumps viruswild typeRNAParamyxoviridaeNoneYesNoNoATCCHuman prostate cancer cell linePC-35000 cells per wellNAMTT assay1 MOI60% cell viability after day 3NoNoNA No responseNAVirus in combination with induce apiptosis in cancer cellNANA29485292
OV_3634Mumps viruswild typeRNAParamyxoviridaeNoneYesNoNoATCCHuman prostate cancer cell linePC-35000 cells per wellNAMTT assay1 MOI10% cell viability after day 6NoNoNA No responseNAVirus in combination with induce apiptosis in cancer cellNANA29485292
OV_3647Measles and mumps viruswild typeRNAParamyxoviridaeNoneNoMeasles virus in combination with mumps virusNoATCCHuman prostate cancer cell linePC-35000 cells per wellNAMTT assay1 MOI30% cell viability after day 3NoNoNA No responseNAVirus in combination with induce apiptosis in cancer cellNANA29485292
OV_3648Measles and mumps viruswild typeRNAParamyxoviridaeNoneNoMeasles virus in combination with mumps virusNoATCCHuman prostate cancer cell linePC-35000 cells per wellNAMTT assay1 MOI12% cell viability after day 6NoNoNA No responseNAVirus in combination with induce apiptosis in cancer cellNANA29485292
OV_3723Vesicular stomatitis virusVSV-GPRNARhabdoviridaevirus expressing GP proteinYesNoNoATCCHuman prostate cancer cell linePC-3NANAAbsorbance measurements0.1 MOI15% cell viableNoNoNA No responseVirus induce apoptosis in cancer cellNANANA29696636
OV_3724Vesicular stomatitis virusVSV-GPRNARhabdoviridaevirus expressing GP proteinYesNoNoATCCHuman prostate cancer cell linePC-3M-LucNANAAbsorbance measurements0.1 MOI50% cell viableNoNoNA No responseVirus induce apoptosis in cancer cellNANANA29696636
OV_3725Vesicular stomatitis virusVSV-GPRNARhabdoviridaevirus expressing GP proteinYesNoNoATCCHuman prostate cancer cell lineDu145NANAAbsorbance measurements0.1 MOI1% cell viableNoNoNA No responseVirus induce apoptosis in cancer cellNANANA29696636
OV_3726Vesicular stomatitis virusVSV-GPRNARhabdoviridaevirus expressing GP proteinYesNoNoATCCHuman prostate cancer cell lineLNCaPNANAAbsorbance measurements0.1 MOI70% cell viableNoNoNA No responseVirus induce apoptosis in cancer cellNANANA29696636
OV_3727Vesicular stomatitis virusVSV-GPRNARhabdoviridaevirus expressing GP proteinYesNoNoATCCHuman prostate cancer cell lineVCaPNANAAbsorbance measurements0.1 MOI70% cell viableNoNoNA No responseVirus induce apoptosis in cancer cellNANANA29696636
OV_3728Vesicular stomatitis virusVSV-GPRNARhabdoviridaevirus expressing GP proteinYesNoNoATCCHuman prostate cancer cell lineLAPC4NANAAbsorbance measurements0.1 MOI30% cell viableNoNoNA No responseVirus induce apoptosis in cancer cellNANANA29696636
OV_3729Vesicular stomatitis virusVSV-GPRNARhabdoviridaevirus expressing GP proteinYesNoNoATCCHuman prostate cancer cell lineTRAMP-C1NANAAbsorbance measurements0.1 MOI5% cell viableNoNoNA No responseVirus induce apoptosis in cancer cellNANANA29696636
OV_3730Vesicular stomatitis virusVSV-GPRNARhabdoviridaevirus expressing GP proteinYesNoNoATCCHuman prostate cancer cell linePC-3NANAAbsorbance measurements10 MOI15% cell viableNoNoNA No responseVirus induce apoptosis in cancer cellNANANA29696636
OV_3731Vesicular stomatitis virusVSV-GPRNARhabdoviridaevirus expressing GP proteinYesNoNoATCCHuman prostate cancer cell linePC-3M-LucNANAAbsorbance measurements10 MOI18% cell viableNoNoNA No responseVirus induce apoptosis in cancer cellNANANA29696636
OV_3732Vesicular stomatitis virusVSV-GPRNARhabdoviridaevirus expressing GP proteinYesNoNoATCCHuman prostate cancer cell lineDu145NANAAbsorbance measurements10 MOI3% cell viableNoNoNA No responseVirus induce apoptosis in cancer cellNANANA29696636
OV_3733Vesicular stomatitis virusVSV-GPRNARhabdoviridaevirus expressing GP proteinYesNoNoATCCHuman prostate cancer cell lineLNCaPNANAAbsorbance measurements10 MOI15% cell viableNoNoNA No responseVirus induce apoptosis in cancer cellNANANA29696636
OV_3734Vesicular stomatitis virusVSV-GPRNARhabdoviridaevirus expressing GP proteinYesNoNoATCCHuman prostate cancer cell lineVCaPNANAAbsorbance measurements10 MOI30% cell viableNoNoNA No responseVirus induce apoptosis in cancer cellNANANA29696636